Skip to main content

Day: February 15, 2022

Travel Retail Market Trends (2022-2029) | Travel Retail Industry Share, Growth Drivers, and Business Opportunities

Companies covered in travel retail market report are Lagardere Group, Dufry AG, UNIFREE, Medreich, Lotte Corporation, Knight Frank, THE SHILLA DUTY FREE, LVMH Moet Hennessy, Louis Vuitton, China International Travel Service Corporation Limited, and other players profiled Pune, India, Feb. 15, 2022 (GLOBE NEWSWIRE) — The global travel retail market size is expected to gain momentum owing to the rising number of international passengers during the forecast period. This information is published by Fortune Business Insights™ in an upcoming report, titled, “Travel Retail Market, 2022-2029.” The surge in travel and tourism has increased demand in the industry for clothes, cosmetics, culinary products, and technology retail. Increasing urbanization and social changes are projected to drive the growth of the global market throughout the...

Continue reading

Avid Technology Announces Conference Call to Discuss Fourth Quarter and Full-Year 2021 Financial Results

BURLINGTON, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) — Avid® (NASDAQ: AVID), a leading technology provider that powers the media and entertainment industry, announced today that Jeff Rosica, Chief Executive Officer and President, and Ken Gayron, Chief Financial Officer and Executive Vice President, will host a conference call on Tuesday, March 1, 2022, at 5:30 p.m. ET to discuss the company’s earnings for the fourth quarter and full-year 2021, ended December 31, 2021, which will be published after the market closes that day. Conference call information:Date & time: Tuesday, March 1, 2022, 5:30 p.m. Eastern Time Webcast link (listen only) and presentation slides: Events & Presentations tab at https://ir.avid.com/ Audio dial-in number: +1 646-828-8193, confirmation code: 7636999A replay of the conference call webcast...

Continue reading

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $37.3 Million for January 2022

— EXPAREL average daily sales for January 2022 were 104% of January 2021 — TAMPA, Fla., Feb. 15, 2022 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited net product sales for EXPAREL® (bupivacaine liposome injectable suspension) and iovera° for the month of January 2022. EXPAREL net product sales were $36.3 million, compared with $34.9 million for January 2021. EXPAREL average daily sales for the month of January 2022 were 104 percent of January 2021. The company reports average daily growth rates for EXPAREL to account for differences in the number of selling days per reporting period. The number of EXPAREL selling days were 20 in both January 2022 and January 2021. Net...

Continue reading

Ero Copper’s Board of Directors Approves Construction of Boa Esperança Project

(all amounts in US dollars, unless otherwise noted) VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) — Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to announce that its Board of Directors has approved the construction of the Boa Esperança Project (“Boa” or the “Project”) located in Pará State, Brazil. Construction is expected to commence in the second quarter of this year, and the Company anticipates achieving first production during the third quarter of 2024. In preparation for construction of Boa, the Company has made significant progress on key workstreams, including:Advancing critical-path contracts including early works, power infrastructure and site construction with equipment mobilization expected in April;Detailed engineering and construction designs;...

Continue reading

Benchmark Specialty Insurance Company Attains “A” Ratings From AM Best

WAYZATA, Minn., Feb. 15, 2022 (GLOBE NEWSWIRE) — Trean Insurance Group, Inc. (Nasdaq: TIG), a leading provider of products and services to the specialty insurance market, announced today that its subsidiary, Benchmark Specialty Insurance Company (BSIC), an Arkansas domestic surplus lines carrier, attained a Financial Strength rating of “A” (Excellent) and a Long-Term Issuer Credit rating of “a” (Excellent) from AM Best, a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. BSIC’s ratings were awarded due to a 100% quota share reinsurance contract with Benchmark Insurance Company, highlighting Benchmark Insurance Company’s balance sheet strength, operating performance, limited business profile and appropriate enterprise risk management. “We are very pleased that AM Best...

Continue reading

China Xiangtai Food Co., Ltd. Announces Nasdaq Ticker Symbol Change from “PLIN” to “BTOG”

Ticker symbol change effective at the market open on February 15, 2022 CHONGQING, China, Feb. 15, 2022 (GLOBE NEWSWIRE) — China Xiangtai Food Co., Ltd. (NASDAQ: PLIN) (“China Xiangtai ” or the “Company”), an emerging growth company engaged in agricultural business with a diversified expansion strategy, today announced that its ticker symbol on the Nasdaq Stock Market (”Nasdaq”) will change to “BTOG” effective at the open of market trading on Tuesday, February 15, 2022. China Xiangtai has traded under the ticker “PLIN” since the Company’s initial public offering in 2019. “The ticker symbol ‘BTOG’ contains ‘BT’, indicating the meaning of ‘bit’ or ‘blockchain’, and ‘OG’, representing ‘Origin’ or the mindset of from past origin to a shared future for humankind.” Ms. Zeshu Dai, Chief Executive...

Continue reading

IPG Photonics Announces Fourth Quarter 2021 Financial Results and Record Annual Revenue

Strong Demand in Europe, North America and Japan Drives Sales Increasing Contribution from Emerging Growth Products Further Diversifies Revenue Authorization of New $200 Million Stock Buyback Program OXFORD, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the fourth quarter ended December 31, 2021.    Three Months Ended December 31,       Twelve Months Ended December 31,    (In millions, except per share data and percentages)     2021       2020     Change     2021       2020     ChangeRevenue   $ 364.5     $ 336.6     8 %   $ 1,460.9     $ 1,200.7     22 %Gross margin     45.5 %     43.6 %         47.7 %     44.9 %    Operating income   $ 84.8     $ 65.2     30 %   $ 367.9     $ 198.7     85 %Operating margin     23.3 %     19.4 %         25.2 %     16.5 %    Net...

Continue reading

Zogenix Supports New No-Cost Genetic Testing Program with United Mitochondrial Disease Foundation to Improve Diagnosis of Mitochondrial Diseases

Symptoms of mitochondrial diseases, such as Thymidine Kinase 2 deficiency (TK2d), can vary widely and mimic other rare and common diseases, making diagnosis challenging 1,2,3 Genetic testing offers a quicker, confirmatory path to diagnosis, enabling more accurate care and participation in available clinical trials 1,2,3 An estimated 1 in 5,000 individuals has a genetic mitochondrial disease 4EMERYVILLE, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing rare disease therapies, today announced that the company is sponsoring a new no-cost genetic testing program, the United Mitochondrial Disease Foundation (UMDF) Pilot Genetic Testing Project, in partnership with UMDF and Probably Genetic, to help patients obtain a confirmed genetic diagnosis of mitochondrial disease....

Continue reading

Independence Gold Commences 4,200 Metre Drill Program at 3Ts Project, BC

VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) — Independence Gold Corp. (TSX.V: IGO)(OTCQB: IEGCF) (the “Company”) is pleased to announce the commencement of a diamond drilling program at its 100% owned 3Ts Project, located approximately 185 kilometres (“km”) southwest of Prince George, British Columbia and situated 20 km southwest of Artemis Gold Inc.’s Blackwater Project. The winter drill program will consist of approximately 15 planned drill holes totaling 4,200 metres (“m”). The targets are based on the 3D geological model of the 3Ts epithermal vein systems, combined with the results from the 2021 drill program, an Induced Polarization (IP) and resistivity survey, and surface geochemistry. Drilling will focus on testing significant gaps within and outside the historical drilling of the Tommy and Ted-Mint vein...

Continue reading

EMCORE Announces Definitive Agreement to Acquire the L3Harris Space and Navigation Business

ALHAMBRA, CA, Feb. 15, 2022 (GLOBE NEWSWIRE) — EMCORE Corporation (Nasdaq: EMKR), a leading provider of advanced mixed-signal products that serve the aerospace & defense, communications, and sensing markets, announced today that it has entered into a definitive agreement to acquire the assets and liabilities of the L3Harris (NYSE: LHX) Space and Navigation Business for approximately $5 million in an all-cash transaction. EMCORE will host a conference call to discuss the acquisition on February 15, 2022. See conference call information below. “L3Harris Space and Navigation designs and builds some of the most accurate Navigation products in the world. This acquisition expands our Fiber Optic Gyroscope (FOG) product portfolio into the Strategic Grade and Space-Qualified markets. We will also gain a technical team with a sterling...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.